Correspondence 0001193125-25-009593 from Cellectis S.A. (CLLS)
Cellectis S.A.
Date: Jan. 21, 2025 · CIK: 0001627281 · Accession: 0001193125-25-009593
AI Filing Summary & Sentiment
File numbers found in text: 333-284302
Show Raw Text
CORRESP 1 filename1.htm CORRESP Cellectis S.A. 8, rue de la Croix Jarry 75013 Paris, France January 21, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Jason Drory RE: Cellectis S.A. Registration Statement on Form F-3 (File No. 333-284302) Dear Mr. Drory: In accordance with Rules 460 and 461 under the Securities Act of 1933, as amended, Cellectis S.A. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-3 to become effective on January 23, 2025 at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant also hereby requests that the Commission notify Peter Devlin of Jones Day at 212-326-3978 or pdevlin@jonesday.com to confirm that the Registration Statement has become effective. Please contact Peter Devlin of Jones Day if you have any questions concerning the foregoing. Thank you for your attention to this matter. Very truly yours, CELLECTIS S.A. By: /s/ André Choulika Name: André Choulika Title: Chief Executive Officer cc: Peter Devlin, Jones Day